Astec LifeSciences
Agri · NSE
52W Low
₹513
+6.3% from low
52W High
₹998
-45.4% from high
Valuation Gauge
Current Price
₹546
Fair Value
—
Fair Value Analysis
—
Loss-making company — EPS ₹-52.19, PAT ₹-104Cr, Revenue ₹397Cr. Standard valuation formulas (DCF/Graham/Lynch) are not applicable for loss-making companies. Monitor for return to profitability.
Price vs Market
Shareholding Pattern
Stock Health Score
Weak Fundamentals
Profitability
Negative EPS of ₹-52.2 — company is currently loss-making
Debt & Leverage
D/E ratio of 0.9x is manageable for Agri sector (norm: 0.8x)
Valuation vs Peers
P/E of 34.6x trades at a significant premium to Agri sector median (25x)
Cash Flow
Negative FCF of ₹-30 Cr — company is consuming more cash than it generates
Earnings Growth
Growth data unavailable — scored neutral
Dividend
No dividend — typical for growth-stage companies
Sentiment Trend — Last 30 Days
Historical Returns
Key Ratios & Growth
FCF Yield
-1.9%
Free cash flow / market cap
Revenue Growth (YoY)
+121.6%
Year-on-year revenue change
Profit Growth (YoY)
-97.5%
Year-on-year PAT change
Operating Cash Flow
₹-8 Cr
TTM cash from operations
Key Financials
EPS (TTM)
₹-52.2
P/E Ratio
34.6x
P/B Ratio
3x
ROE
-25.2%
ROCE
-20.3%
Debt / Equity
0.89x
Beta
-0.14
Div Yield
—
FCF (Cr)
₹-30 Cr
Revenue (Cr)
₹381 Cr
EPS Growth 5Y
—
Mkt Cap (Cr)
₹1,210 Cr
52W High
₹998.4
52W Low
₹513.4
Book Value/Share
₹182.4
Financial History
| Period | Revenue | Op Profit | OPM% | PAT | EPS |
|---|---|---|---|---|---|
| TTM | ₹409 Cr | ₹-8 Cr | -2.0% | ₹-89 Cr | ₹-39.94 |
| 2025-03-31 | ₹381 Cr | ₹-66 Cr | -17.0% | ₹-135 Cr | ₹-60.16 |
| 2024-03-31 | ₹458 Cr | ₹-6 Cr | -1.0% | ₹-47 Cr | ₹-20.95 |
| 2023-03-31 | ₹628 Cr | ₹77 Cr | 12.0% | ₹26 Cr | ₹11.41 |
| 2022-03-31 | ₹677 Cr | ₹154 Cr | 23.0% | ₹90 Cr | ₹40.12 |
| 2021-03-31 | ₹555 Cr | ₹112 Cr | 20.0% | ₹65 Cr | ₹29.04 |
| 2020-03-31 | ₹523 Cr | ₹85 Cr | 16.0% | ₹48 Cr | ₹21.21 |
| 2019-03-31 | ₹431 Cr | ₹76 Cr | 18.0% | ₹36 Cr | ₹16.03 |
| 2018-03-31 | ₹368 Cr | ₹69 Cr | 19.0% | ₹35 Cr | ₹15.65 |
| 2017-03-31 | ₹299 Cr | ₹63 Cr | 21.0% | ₹19 Cr | ₹8.57 |
| 2016-03-31 | ₹233 Cr | ₹32 Cr | 14.0% | ₹5 Cr | ₹2.24 |
| 2015-03-31 | ₹267 Cr | ₹54 Cr | 20.0% | ₹15 Cr | ₹6.66 |
| 2014-03-31 | ₹207 Cr | ₹35 Cr | 17.0% | ₹9 Cr | ₹4.09 |
Compounded Growth Rates
Sales Growth
Profit Growth
EPS Growth
Peer Comparison
Agri| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
Chambal Fertilizers | ₹447 | ₹955.6 | +53.2% | 9.5 | 19.4% | UNDERVALUED |
Paradeep Phosphates | ₹115.9 | ₹235.6 | +50.8% | 11.4 | 15.6% | FAIRLY_VALUED |
EID Parry India | ₹813.6 | ₹1,337.6 | +39.2% | 12.1 | 25.5% | FAIRLY_VALUED |
Dhanuka Agritech | ₹973.1 | ₹1,159.8 | +16.1% | 6.2 | 19.7% | FAIRLY_VALUED |
LT Foods Limited | ₹384 | ₹374.4 | -2.6% | 20.6 | 15.5% | FAIRLY_VALUED |
Coromandel International | ₹1,884 | ₹1,625.2 | -15.9% | 23.1 | 19.4% | FAIRLY_VALUED |
PI Industries | ₹2,837.1 | ₹2,442.6 | -16.1% | 29.2 | 17.1% | FAIRLY_VALUED |
Gujarat Narmada Valley Fertilizers | ₹405.2 | ₹325 | -24.7% | 9.4 | 5.6% | OVERVALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Company Documents
Annual reports, concall transcripts & regulatory filings
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant
What is Dalal Street saying?
r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket
No Reddit mentions found yet for ASTEC.
StockTwits
What traders are saying right now
No StockTwits activity found for ASTEC.
Telegram Channels
ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit
No Telegram mentions found yet for ASTEC.
Analyst Note
2d ago
Astec LifeSciences trades at ₹545.5 with a valuation signal of CAUTION due to multiple red flags: the company is loss-making with negative free cash flow of ₹30 Cr and deteriorating ROCE of -20.3%. Despite strong revenue growth of 32.9% year-on-year, the high PE of 37.9x and elevated debt-to-equity of 0.89x raise concerns about sustainability. The stock trades near its 52-week low with weak technicals, and the Piotroski score of 2 signals poor financial health. This profile suits only risk-tolerant investors who believe in turnaround potential.
No company news found yet.
Search Interest
Google Trends · India · Last 90 days
Trend data not yet available — check back soon.